Tag : immunotherapies

Clinical Research, Pharma & Healthcare Financing

Nuravax, IMM to Present Alzheimer’s Vaccine Data at CTAD 2025

PR Newswire
by PR Newswire066
Two oral presentations to highlight the safety, immunogenicity, and future development of AV-1959R for primary and secondary prevention of Alzheimer’s disease Nuravax Inc., a clinical-stage...
Clinical Research, Pharma & Healthcare Financing

EvolveImmune, MSK Partner on Bladder Cancer Target Study

GlobeNewswire
by GlobeNewswire0144
EvolveImmune Therapeutics, an immuno-oncology company developing next-generation T cell engager biotherapeutics to overcome cancer cell resistance to current immunotherapies, today announced a translational research collaboration...
Workforce Development & Leadership

iOncologi Appoints Dr. Mona Flores and Mr. Paolo Fundarò to Board

PR Newswire
by PR Newswire0148
iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer treatment, today announced the appointment of Dr. Mona Flores and Mr. Paolo Fundarò to its...
Clinical Research, Pharma & Healthcare Financing

MAIA Biotechnology Announces $1.43M Private Placement

Business Wire
by Business Wire0150
MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive...